Amended number of shares and votes in NeuroVive Pharmaceutical AB (publ)
Lund, Sweden, 30 November 2017 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced an increase of the number of shares and votes in NeuroVive of 1,760,000 as a result of a directed share issue in NeuroVive Pharmaceutical AB, resolved by the Board of Directors on 2 November 2017.Today, the last trading day of the month, there are in total 52,326,197 shares and votes in NeuroVive Pharmaceutical AB. This information is information that NeuroVive Pharmaceutical AB (publ) is obliged to make public pursuant to the EU Market